The Latest Breaking News from SPGI

This outperforming dividend stock, up 31% already over the past year, still has double-digit upside potential – making it a compelling choice for investors right now.

With S&P Global expected to release its Q2 earnings later this month, analysts project a double-digit bottom-line growth.

S&P Global has been significantly underperforming Nasdaq, but Wall Street analysts are bullish about the stock’s recovery prospects.

Discover why S&P Global, a seasoned Dividend King, has not only secured a spot on Bank of America's prestigious US 1 List, but also why analysts are bullish about its investment potential in the current economic climate.

Not all dividend kings are alike. These are the top-rated ones on the list of investors are buying.

Morgan Stanley is betting on these stocks to benefit from the AI megatrend.

Take a look at four of the highest-rated Dividend Aristocrats in the market right now.

S&P Global (SPGI) will release its fourth-quarter results on February 8. Analysts expect the company to report a year-over-year increase in revenue and earnings for the quarter. Moreover, the company is expected to finish fiscal 2023 on a solid note. Therefore, should investors consider buying the stock now? Read on…

In the unpredictable 2023 stock market, dividend kings like SPGI, WMT, and PPG, can provide relative stability for investors seeking reliable income, solid business models, and resilient price action.

Looking for stable returns? We examine three professional services companies with >20% upside potential.

As inflation hit above estimated levels in June, growing concerns over the Fed’s aggressive interest rate hikes and a consequent recession drove a sell-off this week. Since the market volatility is not expected to lessen soon, dividend-paying stocks West Pharmaceutical (WST), S&P Global (SPGI), and Sherwin-Williams (SHW), currently trading at…